{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:25:34Z","timestamp":1648549534631},"reference-count":31,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background: <\/jats:title>\n<jats:p>Alterations in normal coagulation and hemostasis are critical issues that require special attention in the neurosurgical patient. These disorders pose unique challenges in the management of these patients who often have concurrent acute ischemic and hemorrhagic injuries. Although neurosurgical intervention in such cases may be unavoidable and potentially life-saving, these patients should be closely observed after instrumentation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Case Description: <\/jats:title>\n<jats:p>A 57-year-old male with liver cirrhosis secondary to amyloid light-chain amyloidosis was admitted to the intensive care unit for the management of delayed hydrocephalus. An external ventricular drain (EVD) was placed for the treatment and monitoring of hydrocephalus. Five days after EVD placement, a head computed tomography scan revealed a tract hemorrhage. However, on repeated imaging, the size of the hemorrhage continued to increase despite aggressive blood pressure control and several doses of phytonadione. Extensive coagulopathy workup was remarkable for low factor VII levels. In that setting, recombinant activated factor VII was administered to normalize factor VII levels, and the tract hemorrhage stabilized.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>To the best of our knowledge, this is the first case of spontaneous hemorrhage after EVD placement in the setting of liver cirrhosis-associated factor VII deficiency. Our case highlights the importance of identifying coagulation disorders in neurosurgical patients at high risk for coagulopathy and closely monitoring them postoperatively.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_446_2020","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T05:59:51Z","timestamp":1606283991000},"page":"403","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous hemorrhage after external ventricular drain placement in the setting of low factor VII secondary to liver cirrhosis"],"prefix":"10.25259","volume":"11","author":[{"given":"Melissa Ming Jie","family":"Chua","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin S.","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Aurore","family":"Losman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirav J.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saef","family":"Izzy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, Massachusetts, United States."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"10.25259\/SNI_446_2020\/ref-1","first-page":"131","article-title":"Routine use of vitamin k in the treatment of cirrhosis-related coagulopathy: Is it A-O-K?","volume":"44","author":"Aldrich","year":"2019","journal-title":"Maybe not we say. P T"},{"key":"10.25259\/SNI_446_2020\/ref-2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1067\/mtc.2002.126038","article-title":"Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII","volume":"124","author":"Bui","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.25259\/SNI_446_2020\/ref-3","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jvir.2016.05.039","article-title":"Bleeding risk and management in interventional procedures in chronic liver disease","volume":"27","author":"DeAngelis","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.25259\/SNI_446_2020\/ref-4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000491106","article-title":"Management of coagulopathy during bleeding and invasive procedures in patients with liver failure","volume":"34","author":"Drolz","year":"2018","journal-title":"Visc Med"},{"key":"10.25259\/SNI_446_2020\/ref-5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12288-013-0240-9","article-title":"Rational use of recombinant factor VIIa in clinical practice","volume":"30","author":"Dutta","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.25259\/SNI_446_2020\/ref-6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: The SPOTLIGHT and STOP-IT randomized clinical trials","volume":"76","author":"Gladstone","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.25259\/SNI_446_2020\/ref-7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MOH.0b013e32826388c3","article-title":"Recombinant factor VIIa: Safety and efficacy","volume":"14","author":"Goodnough","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.25259\/SNI_446_2020\/ref-8","article-title":"Aminocaproic acid","volume-title":"Stat Pearls","author":"Kaseer","year":"2020"},{"key":"10.25259\/SNI_446_2020\/ref-9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/sjg.SJG_486_17","article-title":"Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis","volume":"24","author":"Li","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"10.25259\/SNI_446_2020\/ref-10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2010.01.042","article-title":"Hemostasis and thrombosis in patients with liver disease: The ups and downs","volume":"53","author":"Lisman","year":"2010","journal-title":"J Hepatol"},{"key":"10.25259\/SNI_446_2020\/ref-11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ALN.0000000000001467","article-title":"Value of preoperative hemostasis testing in patients with liver disease for perioperative hemostatic management","volume":"126","author":"Lisman","year":"2017","journal-title":"Anesthesiology"},{"key":"10.25259\/SNI_446_2020\/ref-12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_446_2020\/ref-13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3121\/cmr.2014.1237","article-title":"The emergent reversal of coagulopathies encountered in neurosurgery and neurology: A technical note","volume":"13","author":"Medow","year":"2015","journal-title":"Clin Med Res"},{"key":"10.25259\/SNI_446_2020\/ref-14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1665-2681(19)31312-2","article-title":"Coagulation abnormalities in the cirrhotic patient","volume":"12","author":"Muci\u00f1o-Bermejo","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.25259\/SNI_446_2020\/ref-15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: A multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"10.25259\/SNI_446_2020\/ref-16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","article-title":"Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia","volume":"38","author":"Napolitano","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.25259\/SNI_446_2020\/ref-17","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.4081\/hr.2018.7235","article-title":"Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver","volume":"10","author":"Nguyen","year":"2018","journal-title":"Hematol Rep"},{"key":"10.25259\/SNI_446_2020\/ref-18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O\u2019Connell","year":"2006","journal-title":"JAMA"},{"key":"10.25259\/SNI_446_2020\/ref-19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1227\/01.NEU.0000068830.54968.A8","article-title":"Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients","volume":"53","author":"Park","year":"2003","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_446_2020\/ref-20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1055\/s-0037-1614918","article-title":"Acute myocardial infarction following administration of recombinant activated factor VII (Novo seven) in a patient with haemophilia A and inhibitor","volume":"82","author":"Peerlinck","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.25259\/SNI_446_2020\/ref-21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ijpp.12355","article-title":"The effectiveness of intravenous Vitamin K in correcting cirrhosis-associated coagulopathy","volume":"25","author":"Rivosecchi","year":"2017","journal-title":"Int J Pharm Pract"},{"key":"10.25259\/SNI_446_2020\/ref-22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0037-1613110","article-title":"Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient","volume":"87","author":"Rosenfeld","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.25259\/SNI_446_2020\/ref-23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MBC.0b013e32835975ed","article-title":"The coagulopathy of liver disease: Does Vitamin K help?","volume":"24","author":"Saja","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.25259\/SNI_446_2020\/ref-24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000446304","article-title":"Monitoring and treatment of coagulation disorders in end-stage liver disease","volume":"32","author":"Saner","year":"2016","journal-title":"Visc Med"},{"key":"10.25259\/SNI_446_2020\/ref-25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0038-1660523","article-title":"Prevention and management of bleeding risk related to invasive procedures in cirrhosis","volume":"38","author":"Schepis","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.25259\/SNI_446_2020\/ref-26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12664-015-0584-1","article-title":"Coagulopathy in cirrhosis: A prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics","volume":"34","author":"Shah","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.25259\/SNI_446_2020\/ref-27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.amjcard.2012.05.043","article-title":"Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization","volume":"110","author":"Townsend","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.25259\/SNI_446_2020\/ref-28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_446_2020\/ref-29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/B978-0-444-63599-0.00040-5","article-title":"Management of neurologic complications of coagulopathies","volume":"141","author":"Vanderwerf","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.25259\/SNI_446_2020\/ref-30","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.transproceed.2010.05.144","article-title":"Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: Randomized clinical trial","volume":"42","author":"Wang","year":"2010","journal-title":"Transplant Proc"},{"key":"10.25259\/SNI_446_2020\/ref-31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/2193-1801-3-471","article-title":"Recombinant factor VIIa use in patients presenting with intracranial hemorrhage","volume":"3","author":"Yampolsky","year":"2014","journal-title":"Springerplus"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/spontaneous-hemorrhage-after-external-ventricular-drain-placement-in-the-setting-of-low-factor-vii-secondary-to-liver-cirrhosis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/spontaneous-hemorrhage-after-external-ventricular-drain-placement-in-the-setting-of-low-factor-vii-secondary-to-liver-cirrhosis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T05:59:56Z","timestamp":1606283996000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/spontaneous-hemorrhage-after-external-ventricular-drain-placement-in-the-setting-of-low-factor-vii-secondary-to-liver-cirrhosis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":31,"alternative-id":["10.25259\/SNI_446_2020"],"URL":"https:\/\/doi.org\/10.25259\/sni_446_2020","relation":{},"ISSN":["2152-7806"],"issn-type":[{"value":"2152-7806","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"article-number":"403"}}